Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606306 · ClinicalTrials.gov registry record · Phase 3
Individualized Therapy For Asthma in Toddlers
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT01606306 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 300 participants.
The verdict
NCT01606306, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The INFANT study will test whether, in preschool children 12-59 months of age with persistent asthma, the following Step 2 asthma therapies will provide similar degrees of asthma control: 1. Daily inhaled corticosteroid (ICS) treatment, 2. Daily leukotriene receptor antagonist (LTRA) treatment, and 3. As-needed ICS plus short-acting beta agonist (as-needed ICS/SABA) rescue treatment.
Interventions
- DRUG Montelukast
- DRUG daily fluticasone propionate
- DRUG as-needed fluticasone propionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01606306
The ClinicalTrials.gov registry entry for NCT01606306 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Montelukast is the first listed.
NCT01606306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01606306 about?
NCT01606306 is a clinical study titled "Individualized Therapy For Asthma in Toddlers". The INFANT study will test whether, in preschool children 12-59 months of age with persistent asthma, the following Step 2 asthma therapies will provide similar degrees of asthma control: 1. Daily inhaled corticosteroid (ICS) treatment, 2. Daily leukotriene receptor antagonist (LTRA) treatment, and...
What is the current status of trial NCT01606306?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2013-02. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01606306?
The interventions under investigation include: Montelukast (DRUG), daily fluticasone propionate (DRUG), as-needed fluticasone propionate (DRUG).
Who is sponsoring clinical trial NCT01606306?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.